| Literature DB >> 29210616 |
Ha Dinh Thu1, Huong Nguyen Thanh1, Thuy Hua Thanh1, Le Nguyen Hai1, Van Tran Thi2, Tri Nguyen Manh3, Anne Buvé4.
Abstract
HPV vaccine is effective in preventing human papillomavirus, the main cause of cervical cancer. In Vietnam, at first, it was subsidized at $5 a dose and reached the coverage of 96% in two pilot provinces, indicating potentially high acceptance. Currently, it is provided at $120-195 for three doses. This is a cross-sectional study, conducted in two northern rural districts of Vietnam. Researchers present findings to show 53.1% of mothers stated their willingness to pay (WTP) for HPV vaccine for their daughters. Perceptions on cost and condom use were associated with WTP. Mothers' affordability ranged from under $23 to $46. Measures should be implemented soon to make HPV vaccine more affordable.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29210616 DOI: 10.1080/07399332.2017.1411914
Source DB: PubMed Journal: Health Care Women Int ISSN: 0739-9332